Anti-Jo-1 associated disease after inactive COVID-19 vaccine

dc.authorscopusid56725783200
dc.authorscopusid58867276700
dc.authorscopusid55964991700
dc.authorscopusid36805552500
dc.contributor.authorAdemoğlu Z.
dc.contributor.authorErol Kalkan K.
dc.contributor.authorİlgen U.
dc.contributor.authorEmmungil H.
dc.date.accessioned2024-06-12T10:26:22Z
dc.date.available2024-06-12T10:26:22Z
dc.date.issued2022
dc.description.abstract[No abstract available]en_US
dc.identifier.doi10.4274/raed.galenos.2022.66376
dc.identifier.endpage111en_US
dc.identifier.issn2651-2653
dc.identifier.issue2en_US
dc.identifier.scopus2-s2.0-85184177989en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage110en_US
dc.identifier.trdizinid1122063en_US
dc.identifier.urihttps://doi.org/10.4274/raed.galenos.2022.66376
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/1122063
dc.identifier.urihttps://hdl.handle.net/20.500.14551/16806
dc.identifier.volume14en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.publisherGalenos Publishing Houseen_US
dc.relation.ispartofJournal of Turkish Society For Rheumatologyen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAnti-Jo-1; Covid-19; Myositis; Vaccinationen_US
dc.titleAnti-Jo-1 associated disease after inactive COVID-19 vaccineen_US
dc.title.alternativeİnaktif COVID-19 aşısı sonrası anti-Jo-1 ilişkili hastalıken_US
dc.typeLetteren_US

Dosyalar